Search Results for: 3d sound

Primal’s 3D Human Anatomy for Ultrasound Upper & Lower Limb – Video


Primal #39;s 3D Human Anatomy for Ultrasound Upper Lower Limb
As the use of MSK ultrasound becomes more widely used Primal Pictures brings you 3D Human Anatomy for Ultrasound Upper Lower Limb. An invaluable anatomy re...

By: Primal Pictures - 3D Human Anatomy

Read the original:
Primal's 3D Human Anatomy for Ultrasound Upper & Lower Limb - Video

Posted in Anatomy | Comments Off on Primal’s 3D Human Anatomy for Ultrasound Upper & Lower Limb – Video

3D ultrasound to assess the position of tubal sterilization microinserts

BACKGROUND

The aim of this study was to assess the diagnostic accuracy of three-dimensional ultrasound (3D-US) for determining the position of Essure microinserts and the success of sterilization by the Essure method.

METHODS

This retrospective observational study examined the case records of 311 women who underwent hysteroscopic sterilization from October 2002 through October 2008. Imaging with 3D-US or pelvic X-radiography or both was performed 3 months after the procedure to verify device position. Hysterosalpingography (HSG) was performed when a bilateral procedure was not completed because of a history of salpingectomy or blocked tube, when doubt persisted after 3D-US or pelvic radiography, or for comparative purposes in a prospective study. The positions seen on 3D-US were classified in four categories according to a specific scale we devised.

RESULTS

The insertion procedure was completed in 94.2% patients. Only 90.5% underwent imaging verification of the device 3 months afterwards. In all, 227 3D-US, 175 pelvic radiography and 64 HSG imaging procedures were performed. Visualization of the device was possible in 99.6% of the 3D-US images. According to our classification, 3D-US was appropriate for assessing device position for 195 (85.9%) patients. The need for HSG confirmation was significantly lower with 3D-US than radiographic imaging (14.1 versus 26.8%, P = 0.001). 3D-US examinations, compared with the results of HSG as the reference test, had a sensitivity of 100% and a specificity of 76.6%. Neither pregnancy nor early expulsion occurred when 3D-US found that the devices were correctly placed.

CONCLUSIONS

3D-US is a simple technique for assessing the position of Essure® microinserts, even after concomitant endometrial surgery. The 3D-US classification presented here appears to make it possible to use HSG for back-up confirmation only when the microinsert is found in a very distal position on 3D-US and thus to protect the majority of women from the negative effects of pelvic radiography and HSG.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

Posted in Human Reproduction | Comments Off on 3D ultrasound to assess the position of tubal sterilization microinserts

Cancer Patient Develops A Rare Neurological Condition That Replaced His Accent With Irish-sounding Voice – Revyuh

Cancer Patient Develops A Rare Neurological Condition That Replaced His Accent With Irish-sounding Voice  Revyuh

View original post here:
Cancer Patient Develops A Rare Neurological Condition That Replaced His Accent With Irish-sounding Voice - Revyuh

Posted in Neurology | Comments Off on Cancer Patient Develops A Rare Neurological Condition That Replaced His Accent With Irish-sounding Voice – Revyuh

Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside – GlobeNewswire

Lumify abdominal scan

Lumify with Reacts on tablet

June 11, 2020

Amsterdam, the Netherlands Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced thatits Lumify with Reacts handheld tele-ultrasound solution is now commercially available in Japan. Philips has received clearance from Japans healthcare authority to introduce the ultrasound solution for compatible handheld devices [1] in the worlds third largest healthcare market after the US and China. Launched in Japan with a novel subscription model unique in the industry, Philips tele-ultrasound solution aims to make high-quality portable ultrasound available almost everywhere in the country.

Improving the diagnostic imaging experience for patients and staffJapans declining birthrate and aging population makes the need for medical diagnostic equipment that can adapt to these changing demographics more relevant than ever. The portability of Lumify brings a powerful portable diagnostic solution to care professionals in the hospital, enabling them to use ultrasound imaging for bedside diagnosis and to monitor medical conditions. Additionally, Lumify can be easily taken to community settings at the point of care, helping to reduce the need for elderly people to travel to hospitals in Japans larger cities.

"By bringing diagnostic insight to the point of care, Lumify is a great example of how Philips is supporting providers to deliver on the ambition of the quadruple aim in healthcare: better health outcomes, an improved experience for patients and staff, and a lower cost of care, said Matthijs Groot Wassink, General Manager for Access and Obstetric Ultrasound at Philips. Its transducer connects to a smart device such as a tablet, making it a compact and highly durable solution. In addition, by utilizing Philips Lumify with Reacts capability, real-time ultrasound images can be shared between medical staff involved in collaboration during imaging procedures.

Highly versatile, app-based mobile ultrasound Lumify is a highly versatile solution primarily intended for use in places where quick and easy access to diagnostic ultrasound imaging is required. Its portability and ruggedness make it suitable for point-of-care use both in hospitals and in places like ambulances, doctors offices, and patients homes during GP visits. It is also used in remote community healthcare programs such as mother & childcare projects being rolled out by Philips and the Philips Foundation in Africa. In addition to allowing clinicians to remotely collaborate by sharing ultrasound images in real time, Lumifys tele-ultrasound capabilities (Lumify with Reacts) can also be used in medical student and healthcare worker remote training programs.

Philips is a leader in ultrasound solutions with a large global installed base and a strong track record of industry-first innovations in areas such as 3D imaging of the heart, AI-powered quantification tools, and ultra-mobile portable ultrasound solutions. Its ultrasound portfolio supports the effective and efficient delivery of care across a broad range of clinical specialties including radiology, cardiology, point-of-care and obstetrics/gynecology.

Mobilizing Philips resources to combat COVID-19Handheld and portable ultrasound solutions in particular have become valuable tools for clinicians treating COVID-19 patients due to their imaging capabilities, portability and ease of disinfection. Philips ultrasound solutions have been approved in various markets for the management of COVID-19-related lung and cardiac complications, including in Australia, Brazil, Canada, the EU, New Zealand and the US.

Philips has a comprehensive portfolio of services and solutions which can help to support the delivery of high-quality care to COVID-19 patients. It includes secure, connected and intelligent approaches to diagnosis, treatment and predictive monitoring in the hospital, plus screening, remote patient monitoring and care at home. With healthcare under more pressure than ever before, Philips telehealth and AI-enabled data analytics can help support workflows, facilitate remote collaboration and optimize resources. Philips COVID-19-related solutions are designed for rapid deployment and scalability. For more information on how Philips is addressing COVID-19 globally, please visit the Philips centralized COVID-19 hub.

Lumify awarded for benefit to humankindToday, Philips alsoannounced that Lumify has received the 2020 IEEE Spectrum Technology in the Service of Society Award as the technology having the greatest potential to provide the most overall benefit to humankind.

For information on Philips ultrasound solutions, visit https://www.usa.philips.com/healthcare/solutions/ultrasound

[1] In Japan, the local health authority has approved Lumify for use with Panasonics medical-grade handheld devices.

For further information, please contact:

Hans DriessenPhilips Global Press OfficeTel.: +31 6 10 61 04 17E-mail: hans.driessen@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.

See more here:
Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside - GlobeNewswire

Posted in Healthy Living | Comments Off on Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside – GlobeNewswire

3D beating heart tissue experiment heads to Space Station – UW Medicine Newsroom

Note to editors and reporters: Live coverage on NASA Television of the SpaceX CRS-20 cargo launch carrying this experiment is scheduled at 8:30 p.m. EST, 11:30 p.m. PST March 6 and will be replayed twice on March 7. Coverage of the rendezvous with the International Space Station will be at 5:30 a.m. EST Monday, March 8, with installation at 8:30 a.m. All times are subject to change due if weather or launch conditions are unfavorable

MEDIARESOURCES:

Downloads:

Soundbites

Web-embeddable video

Photos of tissue loading

Soundbite Log

Otherresources:

Youtube link

Space exploration can take a toll on the human heart. Astronauts are at risk for changes in their cardiac function and rhythm. To learn how microgravity and other physical forces in space exact their effects on heart muscle, a Tissue Chips in Space project has now been packed and is awaiting launch to the International Space Station.

The experimental equipment consists of small, compact devices, a little bit larger than cell phone cases. The holders contain a row of tiny, 3-D globs of beating heart tissue grown from pluripotent stem cells, generated from human adult cells. The heart muscle tissue is supported between two flexible pillars that allow it to contract freely, in contrast to the rigid constraints of a Petri dish.

The devices also house a novel invention from the University of Washington. It automatically senses and measures the contractions of the heart tissues, and reduces the amount of time the astronauts will need to spend conducting this study.

The flexible pillars contain tiny magnets, explained UW graduate student Ty Higashi, one of the inventors. When the muscle tissue contracts, the position of the embedded magnets changes, and the motion can be detected by a sensor, he said. That information is then sent down to a laboratory on Earth.

This model will recapitulate, on a miniature scale, what might be happening to the architecture and function of heart muscle cells and tissues in astronauts during a space mission.

The project head is Deok-Ho Kim, a professor in bioengineering, who recently joined the Johns Hopkins University faculty in Baltimore. He and co-investigator, Nathan Sniadecki, a professor in mechanical engineering, began this study two years at the UW Medicine Institute for Stem Cell and Regenerative Medicine (ISCRM). Jonathan Tsui, a postdoc in bioengineering, Ty Higashi, a graduate student in mechanical engineering , and other members of the UW project team, continue the cross-country collaboration in Seattle. The team is working with several NASA and National Institutes of Health groups, and researchers at other universities, on this effort.

Sniadecki said that each of the tissues heading to the International Space Center contain about a half million heart cells.

They act like a full tissue, he explained. They contract, they beat and you can actually see them physically shorten in the dish. Were actually able to see little heart beats from these tissues.

The SpaceX shuttle delivering this scientific payload is expected to leave from Cape Canaveral no earlier than 8:50 p.m. PST (11:50 p.m. EST) Friday, March 6. The exact departure schedule depends on the weather and other factors.

Once on board, the experiment will run for 30 days before being returned to Earth for further analysis. A related space-based experiment will follow skyward later, to see if medications or mechanical interventions can offset what the heart muscle endures during extended space missions.

The space program is looking at ways to travel longer and farther, Sniadecki said. To do so, they need to think about protecting their crews. Having treatments or drugs to protect astronauts during their travel would make long term space travel possible.

Guarding against cardiac problems would be especially critical during space travel at distances never attempted before, such as a mission to Mars, said Sniadecki. This opportunity to really kind of push the frontier for space travel is every engineers dream.

He added, We also hope to gather information that will help in preventing and treating heart muscle damage in people generally, as well as in understanding how aging changes heart muscle.

Microgravity is known to speed up aging, and likely influence other cell or tissue properties. Because aging is accelerated in space, studies on the International Space Station is a way to more quickly assess this process over weeks, instead of years.

I think the medicine side of it is extremely helpful on Earth, too, because what we discover could potentially lead to treatments for counteracting aging, Sniadecki said.

This space medicine research project is funded by the National Center for Advancing Translational Sciences and the National Institute of Biomedical Imaging and Bioengineering. This heart tissue study is part of the national Tissue Chips in Space program.

Go here to see the original:
3D beating heart tissue experiment heads to Space Station - UW Medicine Newsroom

Comments Off on 3D beating heart tissue experiment heads to Space Station – UW Medicine Newsroom

GMU students make 3D printed prosthetic arm for violinist | WUSA9 … – W*USA 9

Students from George Mason University design prosthetic arm for violist

Peggy Fox, WUSA 7:28 PM. EDT April 20, 2017

FAIRFAX, VA (WUSA9) - A new beginning for a Fairfax County girl who has just received a new prosthetic arm that was designed and 3-D printed by George Mason University college students.

Isabella Nicola, 10, has been raised by her mother, Andrea Cabrera, to never say never.

"My mom's phrase is, when you say 'I can't do it', it's 'I can't do it yet,'" said Nicola.

The fifth grader signed up to play violin in the strings program at Island Creek Elementary in Franconia last year, even though she knew it'd be a little difficult.

RELATED:Dog rescued from slaughterhouse gets prosthetic legs

She was born with an incomplete left arm. Her music teacher fashioned a makeshift prosthetic arm out of PVC to hold her bow. Then he a called his alma mater and got the engineering department on board.

But now, Isabella has a bright pink, custom-made, brand new prosthetic arm that allows her to hold and move the bow properly.

"I have to say thank you to them because without them I couldn't really be able to play," said Nicola.

The five students have been working as a team for more than a year on their capstone senior project. It was designed, 3D printed, and pieced together by five George Mason University bioengineering students, Yasser Alhindi, the lead, Abdul Gouda, Mona Elkholy, Ella Novoselsky and Racha Salha.

Dr. Elizabeth Adams, a GMU music teacher, explained that a player's arm movement affects the violin's sound. Adams worked with the students and Isabella, providing advice.

The faculty mentors are Wilsaan Joiner and Vasiliki Ikonomidou. Laurence Bray is head of the bioengineering department.

"We were brainstorming ideas right away. We were aiming to take the strain off her shoulder to make her as comfortable as possible," said Ella Novoselsky.

RELATED:Injured animals get life-changing prosthetics

"It's amazing. They didn't have any background when they started, of the mechanical engineering aspect. I'm amazed. When they came to me with all those designs, and they told me, this is going to go there and this will go like that. 'Ok, sure,'" saidVasiliki Ikonomidou, one of the mentors said about the student designers.

For Thursday's hand-off, the students had a surprise for Isabella. They also made a grip so that she can ride bike with both arms. Isabella beamed as she held it like she was holding the handlebars.

"Very cool and nice...They thought about other things. They went above and beyond," said Isabella.

She and the college students hit if off from the start. At their first meeting, Racha Salha said Isabella was "making jokes and laughing. We were actually the ones who were nervous....She's amazing."

"I want her to play the violin and love playing the violin and be excited. And I want her to believe she can do anything she wants," said Ella Novoselsky.

The bioengineering department has already received more inquiries from other people, so another group of students could soon have a new project on their hands.

2017 WUSA-TV

More:
GMU students make 3D printed prosthetic arm for violinist | WUSA9 ... - W*USA 9

Posted in BioEngineering | Comments Off on GMU students make 3D printed prosthetic arm for violinist | WUSA9 … – W*USA 9